Alector Files for IPO to Fund Studies of Alzheimer’s, Dementia Drugs

Alector Files for IPO to Fund Studies of Alzheimer’s, Dementia Drugs

Last year, Alector advanced two drugs into early-stage clinical testing.

Zymergen lands $400 million more, led by SoftBank Vision Fund, for its genetically altered microbes

Zymergen lands $400 million more, led by SoftBank Vision Fund, for its genetically altered microbes

The biggest opportunity for the 600-person company is to produce entirely new products that are untethered to traditional petroleum-based manufacturing.

GenEdit Closes $8.5 million Series Seed Financing

GenEdit Closes $8.5 million Series Seed Financing

The funding will help develop a novel polymer nanoparticle technology platform for non-viral-based delivery of gene therapeutics.

CELLINK partners with Prellis Biologics

CELLINK partners with Prellis Biologics

The two companies will advance the $1.2 million high-precision Holograph-X Bioprinter

Trace Genomics Raises $13 Million To Give Corn And Soybean Farmers Insight Into Soil Health

Trace Genomics Raises $13 Million To Give Corn And Soybean Farmers Insight Into Soil Health

Trace uses machine learning to analyze soil samples for farmers.

Pivot Bio, Bayer Announce Research Collaboration To Enhance Soybean Inoculant

Pivot Bio, Bayer Announce Research Collaboration To Enhance Soybean Inoculant

Pivot is partnering with Monsanto, a Bayer company, to help US soybean farmers boost crop harvests.

Pivot Bio Gets $70M, Led by Bill Gates’s Fund, to Replace Fertilizer

Pivot Bio Gets $70M, Led by Bill Gates’s Fund, to Replace Fertilizer

Pivot’s microbial technology will allow farmers to reduce the use of fertilizers, which can generate potent greenhouse gases.

BriaCell Announces Positive Phase IIa Data in Advanced Breast Cancer

BriaCell Announces Positive Phase IIa Data in Advanced Breast Cancer

To further investigate anti-tumor activity, Briacell will explore combination therapies.

Principia Biopharma announces $100M IPO

Principia Biopharma announces $100M IPO

Principia is a spinoff from Jack Taunton’s lab at UCSF.

Atreca Raises $125 Million

Atreca Raises $125 Million

Atreca was one of the first companies in Mission Bay Capital’s portfolio.